May 01, 2016 + Jessica Di Palo
5 Min read
MTIP reaches important milestones
The investment fund launched by MedTech Innovation Partners AG (MTIP) at the beginning of 2016 made a first closing of CHF 30 million in April. In May 2016, the first investment in ReActive Robotics GmbH was made.
Basel, May 2016: MITP’s first fund which was launched six months ago reached a first close of CHF 30 million in April 2016. The capital was raised by ten different investors including pension funds, family offices, hospitals, foundations. “First-time closing is an enormously important milestone in our industry, one that is difficult to achieve. We are therefore particularly pleased that MTIP has successfully reached its first closing,” emphasises Dr. Christoph Kausch, CEO of MTIP. The target volume of this fund is CHF 40 million. All investments in the fund will be in the same share class and same conditions will apply.
Just as pleasing as the first closing was the first investment MTIP made in May 2016. As the lead investor in ReActive Robotics GmbH, MTIP promotes a company that facilitates the accelerated and improved recovery of patients with the aid of robotic technology. Germany’s largest venture capital fund, the High-Tech Gründerfond, co-invested. Contact with the company had been established via MTIP’s high-caliber advisory board and the associated affiliation to robotics research at the ETH. ReActive Robotics develops adaptive and intelligent therapy robotics which automate Early Mobilization in the intensive care unit. Using robotic modules, which can be attached to the patient bed as required, patients can be mobilised directly in their hospital bed. Thus, in contrast to existing solutions, the time-intensive and often dangerous transfer of intensive care patients onto a separate therapy device is no longer required. The potential market size is estimated to exceed € 2 billion. The device will be launched in Europe in early 2018. “We are delighted to be investing into a business model that offers benefits for patients, the health care system and investors alike,” says Dr. Christoph Kausch. He and his team are already evaluating other attractive startup investments which, in view of the promising investment pipeline, will no doubt follow.
MTIP Closes Second Healthtech Growth Fund Above Target With $250M of Commitments
MTIP Fund II is closed!
Cynerio Now! – A new IoT cybersecurity solution for small hospitals and clinics
Cynerio's new product Cynerio Now!
MTIP invests in Mediktor
New investment in Mediktor
SFDR Art. 8 or Art. 9? What’s the difference?
SFDR: getting the terminology right
MTIP participates in Oviva’s new $80m Series C funding
Oviva raises $80 million financing round
MTIP invests in Intelligencia to reduce the risk of clinical research through artificial intelligence
MTIP's new investment in Intelligencia
Private Equity 101: Part one – Glossary
Are you new to the healthtech space?
Leading brands revolutionize care journeys with Lumeon
How Lumeon orchestrates care journey
Trialbee – our hero in patient matching and recruiting for clinical trials
Trialbee - patient matching and recruiting
Digital healthcare: patient-first?
Digital Healthcare Report 2021 in collaboration with Dealroom and INKEF Capital
SFDR – How does MTIP approach the EU’s Sustainable Disclosure Regulation?
New SFDR obligations
MTIP Announces Strong First Closing of Fund II to drive Healthtech Innovation
First Closing of Fund II
How to pitch to a healthtech Investor
MTIP invests in Koa Health to make mental health treatment more accessible
New investment in Koa Health
MTIP scored fantastic grades in the UNPRI assessment report of 2020
UNPRI Report grades 2020
4 Health VCs Share Their Business Priorities and What is Next
MTIP invests in Trialbee
New investment in Trialbee
TytoCare closes $50 million round as the demand for telehealth accelerates
TytoCare closes new round
The digital healthtech sector is expanding – and so are we!
Two new empolyees start in April
MTIP has sucessfully exited Blueprint Genetics
Blueprint exit January 2020
New MTIP investment in Oviva
New investment in Oviva
Whitepaper: A positive prognosis for the future of healthtech
Our first Whitepaper
Elite Summit 2019 – Interview with our Managing Partner Christoph Kausch
Elite Summit 2019
MTIP Healthcare Clinic 2019
Healthcare clinic 2019
New MTIP investment in Cynerio
New investment in Cynerio